Black Diamond Therapeutics Stock EBITDA
| BDTX Stock | USD 2.57 0.10 4.05% |
Black Diamond Therapeutics fundamentals help investors to digest information that contributes to Black Diamond's financial success or failures. It also enables traders to predict the movement of Black Stock. The fundamental analysis module provides a way to measure Black Diamond's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Black Diamond stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -86 M | -90.3 M |
Black | EBITDA |
Black Diamond Therapeutics Company EBITDA Analysis
Black Diamond's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Black Diamond EBITDA | (86.02 M) |
Most of Black Diamond's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Black Diamond Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Black EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Black Diamond is extremely important. It helps to project a fair market value of Black Stock properly, considering its historical fundamentals such as EBITDA. Since Black Diamond's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Black Diamond's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Black Diamond's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Black Ebitda
According to the company disclosure, Black Diamond Therapeutics reported earnings before interest,tax, depreciation and amortization of (86.02 Million). This is 109.8% lower than that of the Biotechnology sector and 185.89% lower than that of the Health Care industry. The ebitda for all United States stocks is 102.21% higher than that of the company.
Black EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Black Diamond's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Black Diamond could also be used in its relative valuation, which is a method of valuing Black Diamond by comparing valuation metrics of similar companies.Black Diamond is currently under evaluation in ebitda category among its peers.
Black Diamond Current Valuation Drivers
We derive many important indicators used in calculating different scores of Black Diamond from analyzing Black Diamond's financial statements. These drivers represent accounts that assess Black Diamond's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Black Diamond's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4B | 1.1B | 192.9M | 65.4M | 75.2M | 71.4M | |
| Enterprise Value | 1.5B | 1.0B | 155.5M | 59.2M | 68.1M | 64.7M |
Black Diamond ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Black Diamond's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Black Diamond's managers, analysts, and investors.Environmental | Governance | Social |
Black Diamond Institutional Holders
Institutional Holdings refers to the ownership stake in Black Diamond that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Black Diamond's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Black Diamond's value.| Shares | T. Rowe Price Associates, Inc. | 2024-06-30 | 813.1 K | Amvescap Plc. | 2024-06-30 | 712.4 K | Citadel Advisors Llc | 2024-09-30 | 703.7 K | Point72 Asset Management, L.p. | 2024-09-30 | 697.1 K | State Street Corp | 2024-06-30 | 690.4 K | Kennedy Capital Management Inc | 2024-09-30 | 657 K | Driehaus Capital Management Llc | 2024-06-30 | 605.9 K | Octagon Capital Advisors Lp | 2024-09-30 | 594 K | Boxer Capital Llc | 2024-09-30 | 506 K | T. Rowe Price Investment Management,inc. | 2024-09-30 | 10.7 M | Bellevue Group Ag | 2024-09-30 | 8.5 M |
Black Fundamentals
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 55.74 M | ||||
| Shares Outstanding | 56.59 M | ||||
| Shares Owned By Insiders | 2.26 % | ||||
| Shares Owned By Institutions | 98.99 % | ||||
| Number Of Shares Shorted | 5.94 M | ||||
| Price To Book | 1.49 X | ||||
| EBITDA | (86.02 M) | ||||
| Net Income | (82.44 M) | ||||
| Cash And Equivalents | 160.89 M | ||||
| Cash Per Share | 4.43 X | ||||
| Total Debt | 25.3 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 8.55 X | ||||
| Book Value Per Share | 1.72 X | ||||
| Cash Flow From Operations | (66.72 M) | ||||
| Short Ratio | 9.80 X | ||||
| Earnings Per Share | (1.33) X | ||||
| Target Price | 14.5 | ||||
| Number Of Employees | 54 | ||||
| Beta | 2.52 | ||||
| Market Capitalization | 145.42 M | ||||
| Total Asset | 158.57 M | ||||
| Retained Earnings | (417.43 M) | ||||
| Working Capital | 114.39 M | ||||
| Current Asset | 123.51 M | ||||
| Current Liabilities | 4.43 M | ||||
| Net Asset | 158.57 M |
About Black Diamond Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Black Diamond Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Black Diamond using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Black Diamond Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Black Stock Analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.